Cardiac effects of isoliquiritigenin

European Journal of Pharmacology

Volumn 326, Issue 1, 1997, Pages 37-44

  Wegener, Jörg W ^a   Nawrath, Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Ca2+ current; Force of contraction; Fura 2; Guanylyl cyclase; Heart; L type; Phosphodiesterase

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP DERIVATIVE; FORSKOLIN; GUANYLATE CYCLASE; ISOBUTYLMETHYLXANTHINE; ISOLIQUIRITIGENIN; ISOPRENALINE; PHOSPHODIESTERASE;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; FLUORESCENCE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE WALL; IN VITRO STUDY; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALDEHYDE REDUCTASE; ANIMALS; CALCIUM; CHALCONE; CHALCONES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; FEMALE; GUANYLATE CYCLASE; HEART; MALE; MEMBRANE POTENTIALS; MYOCARDIAL CONTRACTION; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030996556     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00134-9     Document Type: Article

References (33)

1. Aida, K., Tawata, M., Shindo, H., Onaya, T., Sasaki, H., Yamaguchi, T., Chin, M., Mitsuhashi, H., 1990. Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix. Planta Med. 56, 254-258.
2. Bäumner, D., Nawrath, H., 1995. Effects of inhibitors of cyclic GMP-dependent protein kinase in atrial heart and aortic smooth muscle from rats. Eur. J. Pharmacol. 273, 295-298.
3. Beavo, J.A., 1988. Multiple isozymes of cyclic nucleotidephosphodiesterase. Adv. Second Messenger Phosphoprotein Res. 22, 1-38.
4. 2+-dependent potassium channels in vascular smooth muscle. Nature 368, 850-853.
5. Brooker, G., 1977. Dissociation of cyclic GMP from the negative inotropic action of carbachol in guinea pig atria. J. Cyclic Nucleotide Res. 3, 407-413.
6. Fischmeister, R., Hartzell, H.C., 1987. Cyclic guanosine 3′,5′-monophosphate regulates the calcium current in single cells from frog ventricle. J. Physiol. (London) 387, 453-472.
7. Garthwaite, J., Southam, E., Boulton, C.L., Nielson, E.B., Schmidt, K., Mayer, B., 1995. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48, 184-188.
8. Goldberg, N.D., Haddox, M.K., Nicol, S.E., Glass, D.B., Sanford, C.H., Kuehl, F.A., Estensen, R., 1975. Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: the Yin Yang hypothesis. Adv. Cyclic Nucleotide Res. 5, 307-330.
9. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
10. Hamill, O.P., Marty, A., Neher, E., Sakmann, B., Sigworth, F.J., 1981. Improved patch-clamp techniques for high resolution current recording from cells and cell free membrane patches. Pflüg. Arch. 391, 85-100.
11. Hare, J.M., Colucci, W.S., 1995. Role of nitric oxide in the regulation of myocardial function. Prog. Cardiovasc. Dis. 38, 155-166.
12. Hartzell, H.C., 1988. Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems. Prog. Biophys. Mol. Biol. 52, 165-247.
13. Ignarro, L.J., 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30, 535-560.
14. Ishibashi, T., Hamaguchi, M., Kato, K., Kawada, T., Ohta, H., Sasage, H., Imai, S., 1993. Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 347, 553-561.
15. Koh, S.D., Campbell, J.D., Carl, A., Sanders, K.M., 1995. Nitric oxide activates multiple potassium channels in canine colonic smooth muscle. J. Physiol. (London) 489, 735-743.
16. Kusano, A., Nikaido, T., Kuge, T., Ohmoto, T., Delle-Monache, G., Botta, B., Botta, M., Saitoh, T., 1991. Inhibition of adenosine 3′,5′-cyclic monophosphate phosphodiesterase by flavonoids from licorice roots and 4-arylcoumarins. Chem. Pharm. Bull. (Tokyo) 39, 930-933.
17. Levi, R.C., Alloatti, G., Fischmeister, R., 1989. Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes. Pflüg. Arch. 413, 685-687.
18. Lincoln, T.M., Keely, S.L., 1981. Regulation of cardiac cyclic GMP-dependent protein kinase. Biochim. Biophys. Acta 676, 230-244.
19. McCall, D., Fried, T.A., 1990. Effect of atriopeptin II on Ca influx, contractile behavior and cyclic nucleotide content of cultured neonatal rat myocardial cells. J. Mol. Cell. Cardiol. 22, 201-212.
20. MacFarland, R.T., 1995. Molecular aspects of cyclic GMP signaling. Zool. Sci. 12, 151-163.
21. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. USA 88, 1197-1201.
22. Moro, M.A., Russel, R.J., Cellek, S., Lizasoain, I., Su, Y., Darley-Usmar, V.M., Radomski, M.W., Moncada, S., 1996. Cyclic GMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA 93, 1480-1485.
23. Nawrath, H., 1976. Cyclic AMP and cyclic GMP may play opposing roles in influencing force of contraction in mammalian myocardium. Nature 262, 509-511.
24. 2+ current in guinea-pig ventricular cells. J. Physiol. (London) 443, 387-404.
25. Reeves, M.L., England, P.J., 1990. Cardiac phosphodiesterases and the functional effects of selective inhibition. In: Beavo, J., Houslay, M.D. (Eds.), Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action. John Wiley & Sons, New York, NY, pp. 299-316.
26. Reuter, H., 1983. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 301, 569-574.
27. Rugg, E.L., Aiton, J.F., Cramb, G., 1989. Atrial natriuretic peptide receptors and activation of guanylate cyclase in rat cardiac sarcolemma. Biochem. Biophys. Res. Commun. 162, 1339-1345.
28. Schaap, P., Van-Ments-Cohen, M., Soede, R.D., Brandt, R., Firtel, R.A., Dostmann, W., Genieser, H.G., Jastorff, B., Van-Haastert, P.J., 1993. Cell-permeable non-hydrolyzable cAMP derivatives as tools for analysis of signaling pathways controlling gene regulation in Dictyostelium. J. Biol. Chem. 268, 6323-6331.
29. Stamler, J.S., Singel, D.J., Loscalzo, J., 1992. Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898-1902.
30. Tohse, N., Sperelakis, N., 1991. cGMP inhibits the activity of single calcium channels in embryonic chick heart cells. Circ. Res. 69, 325-331.
31. Trautwein, W., Osterrieder, W., 1986. Mechanism of β-adrenergic and cholinergic control of Ca and K currents in the heart. In: Nathan, R.D. (Ed.), Cardiac Muscle: The Regulation of Excitation and Contraction. Academic Press, London, pp. 87-128.
32. Wegener, J.W., Nawrath, H., 1995. Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 322-330.
33. Yu, S.M., Kuo, S.C., 1995. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylyl cyclase activator, in rat aorta. Br. J. Pharmacol. 114, 1587-1594.